A02688 Summary:
BILL NO | A02688 |
  | |
SAME AS | SAME AS S06442 |
  | |
SPONSOR | Gottfried (MS) |
  | |
COSPNSR | Paulin, Jacobs, Gunther, Rosenthal, Cahill, Galef, Englebright, Millman, Jaffee, Zebrowski, Hooper, Lupardo, Schimel, Titone, Kellner, Brook-Krasny, Abinanti, Perry, Weprin, Kearns, McDonald |
  | |
MLTSPNSR | Clark |
  | |
Add S2424, Pub Health L | |
  | |
Establishes the clinical trial access and education fund to provide grants to eligible applicants to provide certain services for patients with life-threatening or disabling conditions or diseases. |
A02688 Actions:
BILL NO | A02688 | |||||||||||||||||||||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||||||||||||||||||||
01/17/2013 | referred to health | |||||||||||||||||||||||||||||||||||||||||||||||||
01/29/2013 | reported referred to ways and means | |||||||||||||||||||||||||||||||||||||||||||||||||
06/10/2013 | reported referred to rules | |||||||||||||||||||||||||||||||||||||||||||||||||
06/11/2013 | reported | |||||||||||||||||||||||||||||||||||||||||||||||||
06/11/2013 | rules report cal.184 | |||||||||||||||||||||||||||||||||||||||||||||||||
06/11/2013 | ordered to third reading rules cal.184 | |||||||||||||||||||||||||||||||||||||||||||||||||
06/13/2013 | passed assembly | |||||||||||||||||||||||||||||||||||||||||||||||||
06/13/2013 | delivered to senate | |||||||||||||||||||||||||||||||||||||||||||||||||
06/13/2013 | REFERRED TO HEALTH | |||||||||||||||||||||||||||||||||||||||||||||||||
01/08/2014 | DIED IN SENATE | |||||||||||||||||||||||||||||||||||||||||||||||||
01/08/2014 | RETURNED TO ASSEMBLY | |||||||||||||||||||||||||||||||||||||||||||||||||
01/08/2014 | ordered to third reading cal.153 | |||||||||||||||||||||||||||||||||||||||||||||||||
01/22/2014 | passed assembly | |||||||||||||||||||||||||||||||||||||||||||||||||
01/22/2014 | delivered to senate | |||||||||||||||||||||||||||||||||||||||||||||||||
01/22/2014 | REFERRED TO HEALTH |
A02688 Floor Votes:
Yes
Abbate
Yes
Crespo
Yes
Goodell
Yes
Lupardo
Yes
Paulin
Yes
Simanowitz
Yes
Abinanti
Yes
Crouch
Yes
Gottfried
Yes
Lupinacci
Yes
Peoples-Stokes
Yes
Simotas
Yes
Arroyo
Yes
Curran
Yes
Graf
Yes
Magee
Yes
Perry
Yes
Skartados
Yes
Aubry
Yes
Cusick
Yes
Gunther
Yes
Magnarelli
Yes
Pretlow
Yes
Skoufis
Yes
Barclay
Yes
Cymbrowitz
Yes
Hawley
Yes
Maisel
Yes
Quart
Yes
Solages
Yes
Barrett
ER
DenDekker
Yes
Heastie
Yes
Malliotakis
Yes
Ra
Yes
Stec
Yes
Barron
Yes
Dinowitz
Yes
Hennessey
Yes
Markey
Yes
Rabbitt
Yes
Steck
Yes
Benedetto
Yes
DiPietro
Yes
Hevesi
Yes
Mayer
Yes
Raia
Yes
Stevenson
Yes
Blankenbush
Yes
Duprey
ER
Hikind
Yes
McDonald
Yes
Ramos
Yes
Stirpe
Yes
Borelli
Yes
Englebright
Yes
Hooper
Yes
McDonough
Yes
Reilich
Yes
Sweeney
AB
Boyland
Yes
Espinal
Yes
Jacobs
Yes
McKevitt
ER
Rivera
Yes
Tedisco
Yes
Braunstein
Yes
Fahy
Yes
Jaffee
Yes
McLaughlin
Yes
Roberts
Yes
Tenney
Yes
Brennan
Yes
Farrell
Yes
Johns
Yes
Miller
Yes
Robinson
Yes
Thiele
Yes
Brindisi
Yes
Finch
Yes
Jordan
Yes
Millman
ER
Rodriguez
Yes
Titone
Yes
Bronson
Yes
Fitzpatrick
Yes
Katz
Yes
Montesano
Yes
Rosa
Yes
Titus
Yes
Brook-Krasny
Yes
Friend
Yes
Kavanagh
Yes
Morelle
Yes
Rosenthal
Yes
Walter
Yes
Buchwald
Yes
Gabryszak
Yes
Kearns
Yes
Mosley
Yes
Rozic
Yes
Weinstein
Yes
Butler
Yes
Galef
Yes
Kellner
Yes
Moya
Yes
Russell
Yes
Weisenberg
Yes
Cahill
Yes
Gantt
Yes
Kim
Yes
Nojay
Yes
Ryan
Yes
Weprin
Yes
Camara
Yes
Garbarino
Yes
Kolb
Yes
Nolan
ER
Saladino
Yes
Wright
Yes
Ceretto
Yes
Gibson
Yes
Lalor
Yes
Oaks
Yes
Santabarbara
Yes
Zebrowski
Yes
Clark
Yes
Giglio
Yes
Lavine
Yes
O'Donnell
Yes
Scarborough
Yes
Mr. Speaker
Yes
Colton
Yes
Gjonaj
Yes
Lentol
Yes
Ortiz
Yes
Schimel
Yes
Cook
Yes
Glick
Yes
Lifton
Yes
Otis
Yes
Schimminger
Yes
Corwin
Yes
Goldfeder
Yes
Lopez
Yes
Palmesano
Yes
Sepulveda
‡ Indicates voting via videoconference
Yes
Abbate
Yes
Crouch
Yes
Gunther
ER
Malliotakis
Yes
Pretlow
Yes
Stec
Yes
Abinanti
Yes
Curran
Yes
Hawley
Yes
Markey
Yes
Quart
Yes
Steck
Yes
Arroyo
Yes
Cusick
Yes
Heastie
Yes
Mayer
Yes
Ra
Yes
Stirpe
Yes
Aubry
Yes
Cymbrowitz
Yes
Hennessey
Yes
McDonald
Yes
Raia
Yes
Sweeney
Yes
Barclay
Yes
Davila
Yes
Hevesi
Yes
McDonough
Yes
Ramos
Yes
Tedisco
Yes
Barrett
Yes
DenDekker
Yes
Hikind
Yes
McKevitt
Yes
Rivera
Yes
Tenney
Yes
Benedetto
Yes
Dinowitz
ER
Hooper
Yes
McLaughlin
Yes
Roberts
Yes
Thiele
Yes
Blankenbush
Yes
DiPietro
Yes
Jacobs
Yes
Miller
Yes
Robinson
Yes
Titone
Yes
Borelli
Yes
Duprey
Yes
Jaffee
Yes
Millman
Yes
Rodriguez
Yes
Titus
AB
Boyland
Yes
Englebright
Yes
Johns
Yes
Montesano
Yes
Rosa
Yes
Walter
Yes
Braunstein
Yes
Fahy
ER
Katz
Yes
Morelle
Yes
Rosenthal
Yes
Weinstein
Yes
Brennan
Yes
Farrell
Yes
Kavanagh
Yes
Mosley
Yes
Rozic
Yes
Weisenberg
Yes
Brindisi
Yes
Finch
Yes
Kearns
Yes
Moya
ER
Russell
Yes
Weprin
Yes
Bronson
Yes
Fitzpatrick
AB
Kellner
Yes
Nojay
Yes
Ryan
Yes
Wright
Yes
Brook-Krasny
Yes
Friend
Yes
Kim
ER
Nolan
Yes
Saladino
Yes
Zebrowski
Yes
Buchwald
Yes
Galef
Yes
Kolb
Yes
Oaks
Yes
Santabarbara
Yes
Mr. Speaker
Yes
Butler
Yes
Gantt
Yes
Lalor
Yes
O'Donnell
Yes
Scarborough
Yes
Cahill
Yes
Garbarino
Yes
Lavine
Yes
Ortiz
Yes
Schimel
Yes
Camara
Yes
Giglio
Yes
Lentol
Yes
Otis
Yes
Schimminger
Yes
Ceretto
Yes
Gjonaj
Yes
Lifton
Yes
Palmesano
Yes
Sepulveda
Yes
Clark
Yes
Glick
Yes
Lopez
Yes
Palumbo
Yes
Simanowitz
ER
Colton
Yes
Goldfeder
Yes
Lupardo
Yes
Paulin
Yes
Simotas
Yes
Cook
Yes
Goodell
Yes
Lupinacci
Yes
Peoples-Stokes
Yes
Skartados
Yes
Corwin
Yes
Gottfried
Yes
Magee
Yes
Perry
Yes
Skoufis
Yes
Crespo
Yes
Graf
Yes
Magnarelli
Yes
Pichardo
Yes
Solages
‡ Indicates voting via videoconference
A02688 Text:
Go to top STATE OF NEW YORK ________________________________________________________________________ 2688 2013-2014 Regular Sessions IN ASSEMBLY January 17, 2013 ___________ Introduced by M. of A. GOTTFRIED, PAULIN, JACOBS, GUNTHER, ROSENTHAL, CAHILL, GALEF, ENGLEBRIGHT, MILLMAN, JAFFEE, ZEBROWSKI, MAISEL, HOOP- ER, LUPARDO, SCHIMEL, TITONE, CASTRO, KELLNER, BROOK-KRASNY, ABINANTI -- read once and referred to the Committee on Health AN ACT to amend the public health law, in relation to establishing the clinical trial access and education fund The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. The public health law is amended by adding a new section 2 2424 to read as follows: 3 § 2424. Clinical trial access and education fund. 1. Definitions. For 4 the purposes of this section, the following terms shall have the follow- 5 ing meanings: 6 a. "Eligible applicant" means (i) a medical school that sponsors a 7 clinical trial, (ii) a not-for-profit organization with experience and 8 expertise working with patients with life-threatening or disabling 9 conditions or diseases, (iii) a health care provider organization, asso- 10 ciation or society, (iv) a general hospital defined in article twenty- 11 eight of this chapter, (v) a county or city health department, or (vi) a 12 municipality. 13 b. "Clinical trial" shall have the same meaning as in subdivision 14 two-b of section forty-nine hundred of this chapter. 15 2. Establishment of fund. There is hereby established within the 16 department a clinical trial access and education fund. Subject to appro- 17 priations, the department shall provide grants to eligible applicants on 18 a competitive request for proposal basis to provide one or more of the 19 following services to patients with life-threatening or disabling condi- 20 tions or diseases, as such terms are defined in section forty-nine 21 hundred of this chapter, to facilitate access to or education on clin- 22 ical trials of treatments for the patient's condition or disease: EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD01585-01-3A. 2688 2 1 a. transportation services and lodging to provide patients with access 2 to clinical trials or other related treatments while enrolled in a clin- 3 ical trial or to access testing and other services to determine patient 4 eligibility for a clinical trial; 5 b. patient outreach and education services to educate patients, their 6 families and health care providers about the existence of and how 7 patients may enroll in clinical trials, under section two hundred seven 8 of this chapter; and 9 c. patient navigation services to help patients to determine if they 10 are eligible for clinical trials, to help patients to enroll in clinical 11 trials and to assist patients in dealing with insurance or other issues 12 which serve as barriers to patient enrollment in clinical trials. 13 3. Applications. The commissioner shall establish an application proc- 14 ess by which eligible applicants may apply for a grant under this 15 section. The application shall include: 16 a. the geographic area in which the services shall be provided; 17 b. a detailed description of the services to be provided; 18 c. applicant's experience working with patients with life-threatening 19 or disabling conditions or diseases; 20 d. applicant's ability to provide patient outreach or clinical trial 21 education and navigation services, or coordinate or provide transporta- 22 tion and lodging for patients; and 23 e. any other information that the commissioner deems relevant and 24 appropriate. 25 The commissioner shall give preference to eligible applicants who have 26 experience and expertise working with patients with life-threatening or 27 disabling conditions or diseases and providing patient outreach, educa- 28 tion and health care navigation services. 29 4. Reports. Grantees shall file an annual report with the commission- 30 er, in such form and with such information and data as the commissioner 31 prescribes detailing the expenditure of grant funds and summarizing the 32 efforts undertaken to increase patient access to clinical trials. 33 5. The commissioner shall make regulations reasonably necessary to 34 implement the provisions of this section. 35 § 2. This act shall take effect immediately.